Vimarsana
Biggest News Aggregation in the World

Page 3 - About Lung News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from About Lung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In About Lung Today - Breaking & Trending Today

Daiichi Sankyo Company, Limited: HERTHENA-Lung01 Phase 2 Study of Daiichi Sankyo's Patritumab Deruxtecan Initiated in Patients with EGFR-Mutated NSCLC - Vimarsana News

Daiichi Sankyo Company, Limited: HERTHENA-Lung01 Phase 2 Study of Daiichi Sankyo's Patritumab Deruxtecan Initiated in Patients with EGFR-Mutated NSCLC

(1) Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the first patient has been dosed in HERTHENA-Lung01, a phase 2 study evaluating patritumab deruxtecan, a HER3 directed DXd antibody drug conjugate (ADC), in patients with epidermal growth factor receptor (EGFR)-mutated metastatic or locally advanced non-small cell lung cancer (NSCLC) previously treated with a tyrosine kinase inhibitor (TKI) and platinum-based chemotherapy. Lung cancer is the leading cause of cancer death among both men and women, and accounts for about one-fifth of all cancer deaths globally,...

Daiichi Sankyo: New Biomarker Analyses from Patritumab Deruxtecan Phase 1 Study in Patients with EGFR-Mutated NSCLC Presented at WCLC 2020 - Vimarsana News

Daiichi Sankyo: New Biomarker Analyses from Patritumab Deruxtecan Phase 1 Study in Patients with EGFR-Mutated NSCLC Presented at WCLC 2020

(1) Exploratory biomarker analyses from an ongoing phase 1 study of Daiichi Sankyo Company, Limited's (hereafter, Daiichi Sankyo) patritumab deruxtecan, a HER3 directed DXd antibody drug conjugate (ADC), in patients with previously treated EGFR-mutated metastatic/unresectable non-small cell lung cancer (NSCLC) were highlighted in a poster presentation today at the IASLC 2020 World Conference on Lung Cancer (WCLC), hosted by the International Association for the Study of Lung Cancer. Lung cancer is the leading cause of cancer death among both men and women, and accounts for about one-fifth of ...